BioCentury | Feb 9, 2015
Company News

Institut Pasteur, Myriad Genetics deal

...in about 100 patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative (SATVI)...
BioCentury | Nov 18, 2013
Clinical News

AERAS-456: Phase I/IIa started

...Not-for-profit Aeras and the Danish government institute said the South African Tuberculosis Vaccine Initiative (SATVI) began a 2-part, double-blind, South African...
BioCentury | Dec 12, 2011
Clinical News

IC31: Phase I started

...Not-for-profit Aeras (Rockville, Md.) and Statens Serum Institut (Copenhagen, Denmark) said the South African Tuberculosis Vaccine Initiative (SATVI) began a South...
Items per page:
1 - 3 of 3
BioCentury | Feb 9, 2015
Company News

Institut Pasteur, Myriad Genetics deal

...in about 100 patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative (SATVI)...
BioCentury | Nov 18, 2013
Clinical News

AERAS-456: Phase I/IIa started

...Not-for-profit Aeras and the Danish government institute said the South African Tuberculosis Vaccine Initiative (SATVI) began a 2-part, double-blind, South African...
BioCentury | Dec 12, 2011
Clinical News

IC31: Phase I started

...Not-for-profit Aeras (Rockville, Md.) and Statens Serum Institut (Copenhagen, Denmark) said the South African Tuberculosis Vaccine Initiative (SATVI) began a South...
Items per page:
1 - 3 of 3